منابع مشابه
Common Adverse Effects of Anti-TNF Agents on Gestation
Autoimmune disease has affected up to 50 million Americans, according to the American Autoimmune Related Diseases Association (AARDA) and 75 percent of those affected are women. These inflammatory diseases have variable activity and a lot of women will have to undergo major therapies during and after pregnancy. Many of the women suffering from these disease will improve during gestation. Howeve...
متن کاملDeveloping anti-TNF and biologic agents.
We have witnessed unprecedented advances in the past quarter of the century in our understanding of the pathophysiology of RA. Fortunately, for the majority of people presenting with this condition today, the outlook is much better than it would have been for those a generation ago. Many contemporary trainees in rheumatology might listen with incredulity when their senior colleagues describe th...
متن کاملOnset of psoriasis in patients receiving anti-TNF agents
In the past decade, tumour necrosis factor (TNF) antagonists have been found to be remarkably effective for the treatment of immune-mediated inflammatory disorders such as rheumatoid arthritis and Crohn’s disease. These agents also dramatically lessen inflammation and improve the quality of life in patients with psoriasis and psoriatic arthritis. The TNF-blocking agents have been relatively saf...
متن کاملCan We Predict the Efficacy of Anti-TNF-α Agents?
The use of biologic agents, particularly anti-tumor necrosis factor (TNF)-α, has revolutionized the treatment of inflammatory bowel diseases (IBD), modifying their natural history. Several data on the efficacy of these agents in inducing and maintaining clinical remission have been accumulated over the past two decades: their use avoid the need for steroids therapy, promote mucosal healing, red...
متن کاملSwitching of anti-TNF-α agents in Behçet's disease.
OBJECTIVES Recent reports suggest efficacy of anti-tumour necrosis factor-alpha (TNF-α) therapy in Behçet's disease. However, the switching of anti-TNF-α agents for treatment failure remains unexplored. Our aims were to describe the efficacy and safety of a second anti-TNF-α agent in Behçet's disease patients after failure of a first agent. METHODS In this retrospective case series, 34 Behçet...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Rheumatology
سال: 2018
ISSN: 1759-4790,1759-4804
DOI: 10.1038/s41584-018-0018-4